ASHLEY WALKER: Open Payments
NPI 1245014075 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 46 payments from 8 companies in 2025. Trend: 2023 $269 · 2024 $379 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $256 |
| Alkermes, Inc. | 8 | $193 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Lundbeck LLC | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: INGREZZA, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, FANAPT, COBENFY, CAPLYTA.
Industry payments across TN — which companies pay providers there.
